ATELLICA TM IM TOXOPLASMA IGG / IGM - COFEPRIS Registration 1517R2018 SSA
Access comprehensive regulatory information for ATELLICA TM IM TOXOPLASMA IGG / IGM (ATELLICA TM IM TOXOPLASMA IGG / IGM) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1517R2018 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on June 13, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ATELLICA™ IM TOXOPLASMA IGG (TOXO G) ESTÁ PREVISTO PARA USO DIAGNÓSTICO IN VITRO EN LA DETECCIÓN CUANTITATIVA Y CUALITATIVA DE ANTICUERPOS IGG CONTRA EL TOXOPLASMA GONDII EN SUERO Y PLASMA (EDTA Y HEPARINA) HUMANOS. LA MEDICIÓN DE TOXOPLASMA IG
THE ATELLICA™ IM TOXOPLASMA IGG (TOXO G) ASSAY IS INTENDED FOR IN VITRO DIAGNOSTIC USE IN THE QUANTITATIVE AND QUALITATIVE DETECTION OF IGG ANTIBODIES AGAINST TOXOPLASMA GONDII IN HUMAN SERUM AND PLASMA (EDTA AND HEPARIN). MEASUREMENT OF TOXOPLASMA IG